NCT00323830View on ClinicalTrials.gov

Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

458

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2011

Conditions
Gastric CancerSurgery
Interventions
DRUG

Capecitabine, cisplatin, Radiotherapy (+/-)

Capecitabine, cisplatin + Radiotherapy (randomized)

Trial Locations (1)

Unknown

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00323830 - Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma | Biotech Hunter | Biotech Hunter